HomeInsights52 Week Low Stocks

Venmax Drugs & Pharmaceuticals Ltd 52 Week Low

Venmax Drugs & Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

1.5 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAXDRUGS

YEARLOW

₹ 6.27

Last updated on: Jan 15, 2025

Key Highlights

  • The 52 Week Low of Venmax Drugs & Pharmaceuticals Ltd is ₹ 6.27 as of 15 Jan 25 .

Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd

No data available

Market Price of Venmax Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Venmax Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 202523.03
14 Jan 202522.58
13 Jan 202522.14
10 Jan 202521.71
09 Jan 202521.29
08 Jan 202520.88
07 Jan 202520.48
06 Jan 202520.08
03 Jan 202519.69
02 Jan 202519.31

Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Venmax Drugs & Pharmaceuticals Ltd News Hub

News

Venmax Drugs & Pharmaceuticals to conduct EGM

Venmax Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of t...

Read more

13 Jan 2025 11:36

News

Venmax Drugs & Pharmaceuticals announces board meeting date

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

07 Jan 2025 10:08

News

Venmax Drugs & Pharmaceuticals to table results

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

31 Oct 2024 12:06

News

Venmax Drugs & Pharmaceuticals to hold AGM

Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the...

Read more

27 Aug 2024 14:57

News

Venmax Drugs & Pharmaceuticals to conduct board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

16 Aug 2024 15:26

News

Venmax Drugs & Pharmaceuticals to hold board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

03 Aug 2024 17:19

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Venmax Drugs & Pharmaceuticals Ltd

Why is it important to track the 52-week low of Venmax Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Venmax Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Venmax Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Venmax Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Venmax Drugs & Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Venmax Drugs & Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Venmax Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Venmax Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Venmax Drugs & Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Venmax Drugs & Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Venmax Drugs & Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Venmax Drugs & Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Venmax Drugs & Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions